YSM News & Updates

Researchers identify a potential target for achieving the healthy longevity that can come with calorie restriction; discarded neuroimaging data holds valuable information that could yield new targets for treating psychiatric illness; how first-year medical residents use a unique toolset to find where they fit in a new community.

Cognitive deficits observed in type 1 diabetes may stem from the genetic risk underlying the condition; a machine learning tool can suggest if and when patients with a rare blood cancer should undergo stem cell transplant; a neuroimaging technique could identify one of the most common forms of frontotemporal dementia earlier.

Researchers identified drug candidates that reversed disrupted behaviors in zebrafish models of autism; a Parkinson's disease drug alters the microbiome in a way that counteracts its intended effect; a more accurate view of the molecular activity in brain cells could offer insight into how the activity changes in diseases like Alzheimer’s.

Timely insights from four new studies examining social media impact on teen brains; craving affects decision making differently depending on whether it is for alcohol or cannabis; the role biomarkers are playing in autism research.

Researchers identified biomarkers that could help patients with endometriosis find effective treatment faster; alternative or complementary treatments are linked to lower survival rates in breast cancer patients; new insights into the neurological underpinnings of disruptive youth behaviors could inform intervention development.

New finding on how HIV replicates could point to novel treatments; researchers identify a potential biomarker for pancreatic cancer risk; a protein involved in exercise-induced inflammation could inform therapies for chronic disease and age-related frailty.

Helping parents regulate stress can reduce obesity risk in their children; stiffening of the pulmonary artery could explain age-related declines in heart and lung function; advancements in cancer screening and therapies will help reduce prostate cancer-related mortality, experts predict.

Engineered natural killer cells could lead to off-the-shelf immunotherapy for hard-to-treat cancers; long-living wild mouse may yield clues for healthy aging; lung cell types age at different rates.

New tool could boost development of personalized vaccines for cancer; emergency department clinical trials offer wide-ranging benefits; legal cannabis products leave researchers with concerns.

Yale School of Medicine ranked fourth among U.S. medical schools in NIH funding for 2025; tumors can stave off immune attack by talking to the brain; new algorithm enables researchers to build complete human genomes using standard technology.